BML, Inc. (BMLKF)

Market Cap	894.10M -3.7%
Revenue (ttm)	930.65M +3.9%
Net Income	48.39M +22.6%
EPS	1.32 +26.8%
Shares Out	n/a
PE Ratio	19.09
Forward PE	n/a
Dividend	0.81 (3.21%)
Ex-Dividend Date	Sep 29, 2026

Volume	11,479
Open	25.21
Previous Close	24.10
Day's Range	25.21 - 25.21
52-Week Range	20.30 - 25.21
Beta	0.22
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 11, 2026

About BML, Inc.

BML, Inc. provides contract clinical testing and related services in Japan. The company offers routine laboratory testing, such as biochemical and hematologic examination; special laboratory test, including tumor markers, infectious diseases, hormones, cellular immunity, genetics, bacteriological tests, and other test; specialized testing in oncology, infectious diseases, diabetes, hypertension, allergies, genetics, and more areas, as well as develops Frontier and Symphony automation systems, which automate pre-testing from specimen sorting to ...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1955
• Employees: 4,612
• Stock Exchange: OTCMKTS
• Ticker Symbol: BMLKF

Financial Performance

In fiscal year 2026, BML, Inc.'s revenue was 150.26 billion, an increase of 4.94% compared to the previous year's 143.19 billion. Earnings were 7.75 billion, an increase of 23.71%.

Financial numbers in JPY

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Nov 9, 2026

Data Sources Report a data error